Lynn Tanoue, MD

Lynn Tanoue, MD
Pulmonology, Thoracic Medical Oncology, Pulmonary Critical Care
Accepting new patients? Yes
Referrals required? From physicians only
Patient type treated: Adult

Lynn Tanoue, MD is Professor in the Section of Pulmonary and Critical Care Medicine, and Vice-Chair for Clinical Affairs in the Department of Internal Medicine. Dr. Tanoue received her undergraduate degree from Harvard and medical degree from Yale, and completed training in internal medicine and pulmonary/critical care medicine at Yale New Haven Hospital. Her clinical interests focus on thoracic oncology and lung cancer screening. She is Clinic Chief in the Section of Pulmonary, Critical Care and Sleep Medicine and Director of the Yale Lung Screening and Nodule Program. She established the Yale New Haven Hospital Tuberculosis Outreach Program, which over the past fifteen years has performed tuberculosis screening in thousands of English-as-a-Second-Language students enrolled at the New Haven Center for Adult Education. Dr. Tanoue serves on numerous national committees, including the American College of Chest Physicians lung cancer guidelines writing committee and Thoracic Oncology Network steering committee, the American Thoracic Society Thoracic Oncology Assembly Executive Committee, and the Pulmonary Board and Examination Committee of the American Board of Internal Medicine.

Dr. Tanoue is an active clinician, mentor, and educator at Yale, where she has received a number of awards including the Dean’s Mentors Award, the Department of Internal Medicine Faculty Achievement Award for Clinical Care, and the Leffell Prize for Clinical Excellence. She is President-elect of the Yale New Haven Hospital medical staff. Her contributions to Yale School of Medicine include the founding of the Yale Medical Symphony Orchestra, of which she is a member and President of its Board of Directors.

  • Professor of Medicine (Pulmonary)
  • Clinical Chief, Section of Pulmonary, Critical Care and Sleep Medicine
  • Director, Yale Lung Screening and Nodule Program
  • Vice Chair for Clinical Affairs, Department of Internal Medicine

Clinical Trials

New treatments for many conditions are tested in clinical trials, which ultimately bring lifesaving new drugs and devices to the patients who need them most. By participating in a clinical trial, you may get access to the most advanced treatments for your condition, and help determine their benefits for future patients.